User:Marvin M2/AOPportal/Mission
From WikiPathways
(Difference between revisions)
| Line 1: | Line 1: | ||
The purpose behind the creation of this portal is to create a collection of AOPs on the molecular level for the AOPs that are, or will be created for the [http://www.eu-toxrisk.eu/ EU-ToxRisk] program, in which Open Phacts Foundation is responsible for AOP creation. The subject of the first set of AOPs are linked to the use cases of the EU-ToxRisk program, and there will be a team of experts involved in the creation of each AOP. | The purpose behind the creation of this portal is to create a collection of AOPs on the molecular level for the AOPs that are, or will be created for the [http://www.eu-toxrisk.eu/ EU-ToxRisk] program, in which Open Phacts Foundation is responsible for AOP creation. The subject of the first set of AOPs are linked to the use cases of the EU-ToxRisk program, and there will be a team of experts involved in the creation of each AOP. | ||
The proposed list of the first set of AOPs are: | The proposed list of the first set of AOPs are: | ||
| + | |||
* | * | ||
* | * | ||
| Line 9: | Line 10: | ||
* | * | ||
* | * | ||
| + | |||
| + | |||
Basic strategies and principles for genreal AOPs are described in this paper: | Basic strategies and principles for genreal AOPs are described in this paper: | ||
Villeneuve ''et al.'' (2014). Adverse Outcome Pathway (AOP) Development I: Strategies and Principles. ''Toxicological Sciences'' [https://www.ncbi.nlm.nih.gov/pubmed/25466378 PubMed] | Villeneuve ''et al.'' (2014). Adverse Outcome Pathway (AOP) Development I: Strategies and Principles. ''Toxicological Sciences'' [https://www.ncbi.nlm.nih.gov/pubmed/25466378 PubMed] | ||
Revision as of 09:35, 30 March 2017
The purpose behind the creation of this portal is to create a collection of AOPs on the molecular level for the AOPs that are, or will be created for the EU-ToxRisk program, in which Open Phacts Foundation is responsible for AOP creation. The subject of the first set of AOPs are linked to the use cases of the EU-ToxRisk program, and there will be a team of experts involved in the creation of each AOP. The proposed list of the first set of AOPs are:
Basic strategies and principles for genreal AOPs are described in this paper:
Villeneuve et al. (2014). Adverse Outcome Pathway (AOP) Development I: Strategies and Principles. Toxicological Sciences PubMed
